Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!

CannTrust Plummets Following Health Canada Compliance Issue, Potential Supply Shortage

Courtesy of Benzinga.

CannTrust Plummets Following Health Canada Compliance Issue, Potential Supply Shortage

Read more about our latest Cannabis News! CANNABIS HOME

Canada-based producer of medical and recreational cannabis company CannTrust Holdings Inc (NYSE: CTST) responded to a Health Canada decision that one of its greenhouse facilities is non-compliant with regulations.

What Happened

Canada’s regulatory body said CannTrust had been growing cannabis in five unlicensed rooms at a facility in Pelham, Ontario, between October 2018 and March 2019, the Financial Post reported. During this period the company’s application was pending and was received in April.

Nevertheless, Health Canada placed a hold on around 5,200 kg of dried cannabis and could remain in this state until the regulatory concludes CannTrust is compliant with all regulations. Meanwhile, CannTrust put a voluntary hold on 7,500 kg of dried cannabis in the same rooms that were previously unlicensed.

CannTrust responded and said it has “accepted” the non-compliance finding and has taken actions to “ensure current and future compliance.” CEO Peter Aceto said the non-compliance is the result of “errors in judgment.”

Need more? Click here to see all cannabis news.

Why It’s Important

Quality of cannabis and compliance with regulations is a “priority” for CannTrust, the company said. To better address its priorities, CannTrust named Andrea Kirk as Vice President, Quality. The executive boasts 20 years of relevant experience in the pharmaceutical sector and has been working with the company since March.

CannTrust said the financial impact of Health Canada’s findings will remain “unknown” until the regulatory body completes quality testing of some of its products.

CannTrust shares traded lower by 20.2% to $3.94 in Monday’s pre-market session.

Related Links:

The Week In Cannabis: Canopy Trims Bruce Linton, Congressional Hearings On Ending Marijuana Prohibition

BofA: CannTrust’s Global Expansion ‘Underappreciated’

Read more about our latest Cannabis News! CANNABIS HOME

Posted-In: Cannabis News Legal Top Stories Markets Movers Trading Ideas Best of Benzinga


Do you know someone who would benefit from this information? We can send your friend a strictly confidential, one-time email telling them about this information. Your privacy and your friend's privacy is your business... no spam! Click here and tell a friend!





You must be logged in to make a comment.
You can sign up for a membership or get a FREE Daily News membership or log in

Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!